BCAX – bicara therapeutics inc. (US:NASDAQ)
Stock Stats
News
The Bull Case For Bicara Therapeutics (BCAX) Could Change Following Dual Inclusion In Major Biotech Indices [Yahoo! Finance]
Bicara Therapeutics (NASDAQ:BCAX) was upgraded by analysts at Mizuho to a "hold" rating.
Bicara Therapeutics (NASDAQ:BCAX) was given a new $18.00 price target on by analysts at Mizuho.
Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Form 4 Bicara Therapeutics Inc. For: Dec 16 Filed by: Mazumdar Claire
Form 4 Bicara Therapeutics Inc. For: Dec 15 Filed by: Cohlhepp Ryan
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Form 8-K Bicara Therapeutics Inc. For: Dec 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.